Get a Quote

DESVENLAFAXINE SUCCINATE
CAS NO.: 386750-22-7
Chemical Formula: C16H25NO2•C4H6O4•H2O
Molecular Weight: 399.4800
DMF&GMP status: Please contact us for more details.
Description:
Desvenlafaxine is an antidepressant in a group of drugs called selective serotonin and norepinephrine reuptake inhibitors (SNRIs). Desvenlafaxine affects chemicals in the brain that may be unbalanced in people with depression.Desvenlafaxine is used to treat major depressive disorder.
Approvals
Active Ingredient Dosage Form; Route Strength Proprietary Name Applicant
DESVENLAFAXINE SUCCINATETABLET EXTENDED RELEASE; ORALEQ 100MG BASEDESVENLAFAXINE SUCCINATEALEMBIC PHARMS LTD
DESVENLAFAXINE SUCCINATE TABLET EXTENDED RELEASE; ORAL EQ 50MG BASE DESVENLAFAXINE SUCCINATE ALEMBIC PHARMS LTD
DESVENLAFAXINE SUCCINATE TABLET EXTENDED RELEASE; ORAL EQ 100MG BASE DESVENLAFAXINE SUCCINATE LUPIN LTD
DESVENLAFAXINE SUCCINATE TABLET EXTENDED RELEASE; ORAL EQ 50MG BASE DESVENLAFAXINE SUCCINATE LUPIN LTD
DESVENLAFAXINE SUCCINATE TABLET EXTENDED RELEASE; ORAL EQ 100MG BASE DESVENLAFAXINE SUCCINATE MYLAN PHARMS INC
DESVENLAFAXINE SUCCINATE TABLET EXTENDED RELEASE; ORAL EQ 50MG BASE DESVENLAFAXINE SUCCINATE MYLAN PHARMS INC
DESVENLAFAXINE SUCCINATE TABLET EXTENDED RELEASE; ORAL EQ 100MG BASE DESVENLAFAXINE SUCCINATE ROXANE
DESVENLAFAXINE SUCCINATE TABLET EXTENDED RELEASE; ORAL EQ 50MG BASE DESVENLAFAXINE SUCCINATE ROXANE
DESVENLAFAXINE SUCCINATE EQ 100MG BASE DESVENLAFAXINE SUCCINATE SANDOZ INC
Patent Data
Patent No. Patent Expiration Drug Substance Claim Drug Product Claim Patent Use Code
66738381-Mar-22YU - 860
6673838 1-Mar-22 Y U - 1364
8269040 5-Jul-27 Y
Exclusive Data
Exclusivity Code Exclusivity Expiration
I - 675 Feb -14-2016